Cut-points for the measurement of pain: The choice depends on what you want to study

Pain

Volumn 149, Issue 2, 2010, Pages 163-164

  Farrar, John T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIEF PAIN INVENTORY; DIABETIC NEUROPATHY; EDITORIAL; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RATING SCALE; RELIABILITY; VALIDITY;

ANALGESICS; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DIABETIC NEUROPATHIES; ENDPOINT DETERMINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY);

EID: 77951880493     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.03.013     Document Type: Editorial

References (8)

1. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J, Immpact. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [see comment]. Pain 2005;113:9-19.
2. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S, Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-21.
3. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
4. Hoffman D.L., Sadosky A., Dukes E.M., and Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?. Pain 149 (2010) 194-201
5. Jensen M.P., Smith D.G., Ehde D.M., and Robinson L.R. Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 91 (2001) 317-322
6. Paul S.M., Zelman D.C., Smith M., and Miaskowski C. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 113 (2005) 37-44
7. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., and Cleeland C.S. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61 (1995) 277-284
8. Zelman D.C., Hoffman D.L., Seifeldin R., and Dukes E. Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain 106 (2003) 35-42